Latest Breaking News On - Thomasb acton - Page 1 : comparemela.com

Share Remdesivir is currently the only antiviral drug approved in the U.S. for treating COVID-19 patients. In a paper published this week in Cell Reports, researchers from The University of Texas at Austin, Rensselaer Polytechnic Institute (RPI) and the Icahn School of Medicine at Mount Sinai showed that four drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the coronavirus in cell cultures. These results indicate that a mixture containing remdesivir and a repurposed hepatitis C virus (HCV) drug could potentially function as a combination antiviral therapy for SARS-CoV-2. Such an antiviral could provide an immediate treatment for unvaccinated people who become infected and for vaccinated people whose immunity has waned.

United statesBalasubramanian harishKris whiteThomas kehrerThomasb actonGaetano montelioneAdolfo garcHelena morenoTheresaa ramelotCatherine royerKhushboo bafnaRobertm krugRomel rosalesUniversity of texas at austinIcahn school of medicine at mount sinaiRensselaer polytechnic institute